2 recruiting. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 2 |
| Phase 3 | 1 | Recruiting 1 |
Follow Thyroid Eye Disease: new trials by email Literature Review of Thyroid Eye Disease trials Research Report on Thyroid Eye Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label, Rollover Trial to Evaluate the Efficacy and Safety of AMG 732 in Participants With Thyroid Eye Disease AMG 732 - Thyroid Eye Disease | Phase 2 | Recruiting | Amgen | 30 | 2026-05-07 | 2026-07-23 |
| Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) linsitinib - Thyroid Eye Disease, Graves Orbitopathy | Phase 2 / Phase 3 | Recruiting | Sling Therapeutics, Inc. | 75 | 2023-10-11 | 2025-02-25 |
Graves Ophthalmopathy (2) · Endocrine System Diseases (1) · Exophthalmos (1) · Eye Diseases (1) · Hashimoto Disease (1) · Orbital Diseases (1) · Thyroid Diseases (1)
Autoimmune Diseases (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Goiter (2) · Graves Disease (2) · Hyperthyroidism (2) · Immune System Diseases (2) · Endocrine System Diseases (1) · Exophthalmos (1) · Eye Diseases (1) · Orbital Diseases (1) · Thyroid Diseases (1) · Thyroiditis (1) · Thyroiditis, Autoimmune (1)
3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol (1)
Amgen (1) · Sling Therapeutics, Inc. (1)
United States (2) · Poland (1) · Spain (1) · Taiwan (1)